FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer

​ The US Food and Drug Administration has issued a new warning about the possible risk of developing secondary cancers for cancer patients who have been treated with a form of immunotherapy called chimeric antigen receptor T-cell, or CAR-T cell, therapy. Read More Breaking News, Latest News and Videos | CNN